Anti-Tuberculosis Drug Market, Global Outlook and Forecast 2022-2028

January 2022 | 70 pages | ID: A2B2DCEB1ABBEN
Market Monitor Global

Abstracts

Plastic surgery is another name for medical aesthetic surgery.

This report contains market size and forecasts of Plastic Operation in Global, including the following market information:

Global Plastic Operation Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Plastic Operation market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Facial Plastic Surgery Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Plastic Operation include American Hospital Of Paris, NYU Langone, Brigham Health, MeteoHealth, Mount Sinai, Sutter Health, HCA Healthcare, Sunnybrook and Westchester Medical Center, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Plastic Operation companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Plastic Operation Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Plastic Operation Market Segment Percentages, by Type, 2021 (%)

• Facial Plastic Surgery
• Breast Surgery
• Liposuction
• Others

Global Plastic Operation Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Plastic Operation Market Segment Percentages, by Application, 2021 (%)

• Medical Beauty
• People With Birth Defects
• Others

Global Plastic Operation Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Plastic Operation Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Plastic Operation revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Plastic Operation revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• American Hospital Of Paris
• NYU Langone
• Brigham Health
• MeteoHealth
• Mount Sinai
• Sutter Health
• HCA Healthcare
• Sunnybrook
• Westchester Medical Center
• Chanto
• Grand Plastic Surgery
• Idhospital
• BK Plastic Surgery

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Anti-Tuberculosis Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Anti-Tuberculosis Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANTI-TUBERCULOSIS DRUG OVERALL MARKET SIZE

2.1 Global Anti-Tuberculosis Drug Market Size: 2021 VS 2028
2.2 Global Anti-Tuberculosis Drug Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Anti-Tuberculosis Drug Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Anti-Tuberculosis Drug Players in Global Market
3.2 Top Global Anti-Tuberculosis Drug Companies Ranked by Revenue
3.3 Global Anti-Tuberculosis Drug Revenue by Companies
3.4 Global Anti-Tuberculosis Drug Sales by Companies
3.5 Global Anti-Tuberculosis Drug Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Anti-Tuberculosis Drug Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Anti-Tuberculosis Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anti-Tuberculosis Drug Players in Global Market
  3.8.1 List of Global Tier 1 Anti-Tuberculosis Drug Companies
  3.8.2 List of Global Tier 2 and Tier 3 Anti-Tuberculosis Drug Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Anti-Tuberculosis Drug Market Size Markets, 2021 & 2028
  4.1.2 First-Line Anti-Tuberculosis Drugs
  4.1.3 Second-Line Anti-Tuberculosis Drugs
4.2 By Type - Global Anti-Tuberculosis Drug Revenue & Forecasts
  4.2.1 By Type - Global Anti-Tuberculosis Drug Revenue, 2017-2022
  4.2.2 By Type - Global Anti-Tuberculosis Drug Revenue, 2023-2028
  4.2.3 By Type - Global Anti-Tuberculosis Drug Revenue Market Share, 2017-2028
4.3 By Type - Global Anti-Tuberculosis Drug Sales & Forecasts
  4.3.1 By Type - Global Anti-Tuberculosis Drug Sales, 2017-2022
  4.3.2 By Type - Global Anti-Tuberculosis Drug Sales, 2023-2028
  4.3.3 By Type - Global Anti-Tuberculosis Drug Sales Market Share, 2017-2028
4.4 By Type - Global Anti-Tuberculosis Drug Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Anti-Tuberculosis Drug Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Others
5.2 By Application - Global Anti-Tuberculosis Drug Revenue & Forecasts
  5.2.1 By Application - Global Anti-Tuberculosis Drug Revenue, 2017-2022
  5.2.2 By Application - Global Anti-Tuberculosis Drug Revenue, 2023-2028
  5.2.3 By Application - Global Anti-Tuberculosis Drug Revenue Market Share, 2017-2028
5.3 By Application - Global Anti-Tuberculosis Drug Sales & Forecasts
  5.3.1 By Application - Global Anti-Tuberculosis Drug Sales, 2017-2022
  5.3.2 By Application - Global Anti-Tuberculosis Drug Sales, 2023-2028
  5.3.3 By Application - Global Anti-Tuberculosis Drug Sales Market Share, 2017-2028
5.4 By Application - Global Anti-Tuberculosis Drug Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Anti-Tuberculosis Drug Market Size, 2021 & 2028
6.2 By Region - Global Anti-Tuberculosis Drug Revenue & Forecasts
  6.2.1 By Region - Global Anti-Tuberculosis Drug Revenue, 2017-2022
  6.2.2 By Region - Global Anti-Tuberculosis Drug Revenue, 2023-2028
  6.2.3 By Region - Global Anti-Tuberculosis Drug Revenue Market Share, 2017-2028
6.3 By Region - Global Anti-Tuberculosis Drug Sales & Forecasts
  6.3.1 By Region - Global Anti-Tuberculosis Drug Sales, 2017-2022
  6.3.2 By Region - Global Anti-Tuberculosis Drug Sales, 2023-2028
  6.3.3 By Region - Global Anti-Tuberculosis Drug Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Anti-Tuberculosis Drug Revenue, 2017-2028
  6.4.2 By Country - North America Anti-Tuberculosis Drug Sales, 2017-2028
  6.4.3 US Anti-Tuberculosis Drug Market Size, 2017-2028
  6.4.4 Canada Anti-Tuberculosis Drug Market Size, 2017-2028
  6.4.5 Mexico Anti-Tuberculosis Drug Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Anti-Tuberculosis Drug Revenue, 2017-2028
  6.5.2 By Country - Europe Anti-Tuberculosis Drug Sales, 2017-2028
  6.5.3 Germany Anti-Tuberculosis Drug Market Size, 2017-2028
  6.5.4 France Anti-Tuberculosis Drug Market Size, 2017-2028
  6.5.5 U.K. Anti-Tuberculosis Drug Market Size, 2017-2028
  6.5.6 Italy Anti-Tuberculosis Drug Market Size, 2017-2028
  6.5.7 Russia Anti-Tuberculosis Drug Market Size, 2017-2028
  6.5.8 Nordic Countries Anti-Tuberculosis Drug Market Size, 2017-2028
  6.5.9 Benelux Anti-Tuberculosis Drug Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Anti-Tuberculosis Drug Revenue, 2017-2028
  6.6.2 By Region - Asia Anti-Tuberculosis Drug Sales, 2017-2028
  6.6.3 China Anti-Tuberculosis Drug Market Size, 2017-2028
  6.6.4 Japan Anti-Tuberculosis Drug Market Size, 2017-2028
  6.6.5 South Korea Anti-Tuberculosis Drug Market Size, 2017-2028
  6.6.6 Southeast Asia Anti-Tuberculosis Drug Market Size, 2017-2028
  6.6.7 India Anti-Tuberculosis Drug Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Anti-Tuberculosis Drug Revenue, 2017-2028
  6.7.2 By Country - South America Anti-Tuberculosis Drug Sales, 2017-2028
  6.7.3 Brazil Anti-Tuberculosis Drug Market Size, 2017-2028
  6.7.4 Argentina Anti-Tuberculosis Drug Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Anti-Tuberculosis Drug Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Anti-Tuberculosis Drug Sales, 2017-2028
  6.8.3 Turkey Anti-Tuberculosis Drug Market Size, 2017-2028
  6.8.4 Israel Anti-Tuberculosis Drug Market Size, 2017-2028
  6.8.5 Saudi Arabia Anti-Tuberculosis Drug Market Size, 2017-2028
  6.8.6 UAE Anti-Tuberculosis Drug Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Lupin
  7.1.1 Lupin Corporate Summary
  7.1.2 Lupin Business Overview
  7.1.3 Lupin Anti-Tuberculosis Drug Major Product Offerings
  7.1.4 Lupin Anti-Tuberculosis Drug Sales and Revenue in Global (2017-2022)
  7.1.5 Lupin Key News
7.2 Otsuka
  7.2.1 Otsuka Corporate Summary
  7.2.2 Otsuka Business Overview
  7.2.3 Otsuka Anti-Tuberculosis Drug Major Product Offerings
  7.2.4 Otsuka Anti-Tuberculosis Drug Sales and Revenue in Global (2017-2022)
  7.2.5 Otsuka Key News
7.3 Sanofi
  7.3.1 Sanofi Corporate Summary
  7.3.2 Sanofi Business Overview
  7.3.3 Sanofi Anti-Tuberculosis Drug Major Product Offerings
  7.3.4 Sanofi Anti-Tuberculosis Drug Sales and Revenue in Global (2017-2022)
  7.3.5 Sanofi Key News
7.4 Prizer
  7.4.1 Prizer Corporate Summary
  7.4.2 Prizer Business Overview
  7.4.3 Prizer Anti-Tuberculosis Drug Major Product Offerings
  7.4.4 Prizer Anti-Tuberculosis Drug Sales and Revenue in Global (2017-2022)
  7.4.5 Prizer Key News
7.5 Abbott
  7.5.1 Abbott Corporate Summary
  7.5.2 Abbott Business Overview
  7.5.3 Abbott Anti-Tuberculosis Drug Major Product Offerings
  7.5.4 Abbott Anti-Tuberculosis Drug Sales and Revenue in Global (2017-2022)
  7.5.5 Abbott Key News
7.6 NOVARTIS
  7.6.1 NOVARTIS Corporate Summary
  7.6.2 NOVARTIS Business Overview
  7.6.3 NOVARTIS Anti-Tuberculosis Drug Major Product Offerings
  7.6.4 NOVARTIS Anti-Tuberculosis Drug Sales and Revenue in Global (2017-2022)
  7.6.5 NOVARTIS Key News

8 GLOBAL ANTI-TUBERCULOSIS DRUG PRODUCTION CAPACITY, ANALYSIS

8.1 Global Anti-Tuberculosis Drug Production Capacity, 2017-2028
8.2 Anti-Tuberculosis Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Anti-Tuberculosis Drug Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 ANTI-TUBERCULOSIS DRUG SUPPLY CHAIN ANALYSIS

10.1 Anti-Tuberculosis Drug Industry Value Chain
10.2 Anti-Tuberculosis Drug Upstream Market
10.3 Anti-Tuberculosis Drug Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Anti-Tuberculosis Drug Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Anti-Tuberculosis Drug in Global Market
Table 2. Top Anti-Tuberculosis Drug Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Anti-Tuberculosis Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Anti-Tuberculosis Drug Revenue Share by Companies, 2017-2022
Table 5. Global Anti-Tuberculosis Drug Sales by Companies, (K Units), 2017-2022
Table 6. Global Anti-Tuberculosis Drug Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Anti-Tuberculosis Drug Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Anti-Tuberculosis Drug Product Type
Table 9. List of Global Tier 1 Anti-Tuberculosis Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-Tuberculosis Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Anti-Tuberculosis Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Anti-Tuberculosis Drug Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Anti-Tuberculosis Drug Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Anti-Tuberculosis Drug Sales (K Units), 2017-2022
Table 15. By Type - Global Anti-Tuberculosis Drug Sales (K Units), 2023-2028
Table 16. By Application – Global Anti-Tuberculosis Drug Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Anti-Tuberculosis Drug Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Anti-Tuberculosis Drug Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Anti-Tuberculosis Drug Sales (K Units), 2017-2022
Table 20. By Application - Global Anti-Tuberculosis Drug Sales (K Units), 2023-2028
Table 21. By Region – Global Anti-Tuberculosis Drug Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Anti-Tuberculosis Drug Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Anti-Tuberculosis Drug Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Anti-Tuberculosis Drug Sales (K Units), 2017-2022
Table 25. By Region - Global Anti-Tuberculosis Drug Sales (K Units), 2023-2028
Table 26. By Country - North America Anti-Tuberculosis Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Anti-Tuberculosis Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Anti-Tuberculosis Drug Sales, (K Units), 2017-2022
Table 29. By Country - North America Anti-Tuberculosis Drug Sales, (K Units), 2023-2028
Table 30. By Country - Europe Anti-Tuberculosis Drug Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Anti-Tuberculosis Drug Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Anti-Tuberculosis Drug Sales, (K Units), 2017-2022
Table 33. By Country - Europe Anti-Tuberculosis Drug Sales, (K Units), 2023-2028
Table 34. By Region - Asia Anti-Tuberculosis Drug Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Anti-Tuberculosis Drug Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Anti-Tuberculosis Drug Sales, (K Units), 2017-2022
Table 37. By Region - Asia Anti-Tuberculosis Drug Sales, (K Units), 2023-2028
Table 38. By Country - South America Anti-Tuberculosis Drug Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Anti-Tuberculosis Drug Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Anti-Tuberculosis Drug Sales, (K Units), 2017-2022
Table 41. By Country - South America Anti-Tuberculosis Drug Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Anti-Tuberculosis Drug Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Anti-Tuberculosis Drug Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Anti-Tuberculosis Drug Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Anti-Tuberculosis Drug Sales, (K Units), 2023-2028
Table 46. Lupin Corporate Summary
Table 47. Lupin Anti-Tuberculosis Drug Product Offerings
Table 48. Lupin Anti-Tuberculosis Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Otsuka Corporate Summary
Table 50. Otsuka Anti-Tuberculosis Drug Product Offerings
Table 51. Otsuka Anti-Tuberculosis Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Sanofi Corporate Summary
Table 53. Sanofi Anti-Tuberculosis Drug Product Offerings
Table 54. Sanofi Anti-Tuberculosis Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Prizer Corporate Summary
Table 56. Prizer Anti-Tuberculosis Drug Product Offerings
Table 57. Prizer Anti-Tuberculosis Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Abbott Corporate Summary
Table 59. Abbott Anti-Tuberculosis Drug Product Offerings
Table 60. Abbott Anti-Tuberculosis Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. NOVARTIS Corporate Summary
Table 62. NOVARTIS Anti-Tuberculosis Drug Product Offerings
Table 63. NOVARTIS Anti-Tuberculosis Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Anti-Tuberculosis Drug Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 65. Global Anti-Tuberculosis Drug Capacity Market Share of Key Manufacturers, 2020-2022
Table 66. Global Anti-Tuberculosis Drug Production by Region, 2017-2022 (K Units)
Table 67. Global Anti-Tuberculosis Drug Production by Region, 2023-2028 (K Units)
Table 68. Anti-Tuberculosis Drug Market Opportunities & Trends in Global Market
Table 69. Anti-Tuberculosis Drug Market Drivers in Global Market
Table 70. Anti-Tuberculosis Drug Market Restraints in Global Market
Table 71. Anti-Tuberculosis Drug Raw Materials
Table 72. Anti-Tuberculosis Drug Raw Materials Suppliers in Global Market
Table 73. Typical Anti-Tuberculosis Drug Downstream
Table 74. Anti-Tuberculosis Drug Downstream Clients in Global Market
Table 75. Anti-Tuberculosis Drug Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Anti-Tuberculosis Drug Segment by Type
Figure 2. Anti-Tuberculosis Drug Segment by Application
Figure 3. Global Anti-Tuberculosis Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Anti-Tuberculosis Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Anti-Tuberculosis Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. Anti-Tuberculosis Drug Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Anti-Tuberculosis Drug Revenue in 2021
Figure 9. By Type - Global Anti-Tuberculosis Drug Sales Market Share, 2017-2028
Figure 10. By Type - Global Anti-Tuberculosis Drug Revenue Market Share, 2017-2028
Figure 11. By Type - Global Anti-Tuberculosis Drug Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Anti-Tuberculosis Drug Sales Market Share, 2017-2028
Figure 13. By Application - Global Anti-Tuberculosis Drug Revenue Market Share, 2017-2028
Figure 14. By Application - Global Anti-Tuberculosis Drug Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Anti-Tuberculosis Drug Sales Market Share, 2017-2028
Figure 16. By Region - Global Anti-Tuberculosis Drug Revenue Market Share, 2017-2028
Figure 17. By Country - North America Anti-Tuberculosis Drug Revenue Market Share, 2017-2028
Figure 18. By Country - North America Anti-Tuberculosis Drug Sales Market Share, 2017-2028
Figure 19. US Anti-Tuberculosis Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Anti-Tuberculosis Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Anti-Tuberculosis Drug Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Anti-Tuberculosis Drug Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Anti-Tuberculosis Drug Sales Market Share, 2017-2028
Figure 24. Germany Anti-Tuberculosis Drug Revenue, (US$, Mn), 2017-2028
Figure 25. France Anti-Tuberculosis Drug Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Anti-Tuberculosis Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Anti-Tuberculosis Drug Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Anti-Tuberculosis Drug Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Anti-Tuberculosis Drug Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Anti-Tuberculosis Drug Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Anti-Tuberculosis Drug Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Anti-Tuberculosis Drug Sales Market Share, 2017-2028
Figure 33. China Anti-Tuberculosis Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Anti-Tuberculosis Drug Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Anti-Tuberculosis Drug Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Anti-Tuberculosis Drug Revenue, (US$, Mn), 2017-2028
Figure 37. India Anti-Tuberculosis Drug Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Anti-Tuberculosis Drug Revenue Market Share, 2017-2028
Figure 39. By Country - South America Anti-Tuberculosis Drug Sales Market Share, 2017-2028
Figure 40. Brazil Anti-Tuberculosis Drug Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Anti-Tuberculosis Drug Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Anti-Tuberculosis Drug Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Anti-Tuberculosis Drug Sales Market Share, 2017-2028
Figure 44. Turkey Anti-Tuberculosis Drug Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Anti-Tuberculosis Drug Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Anti-Tuberculosis Drug Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Anti-Tuberculosis Drug Revenue, (US$, Mn), 2017-2028
Figure 48. Global Anti-Tuberculosis Drug Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Anti-Tuberculosis Drug by Region, 2021 VS 2028
Figure 50. Anti-Tuberculosis Drug Industry Value Chain
Figure 51. Marketing Channels